抗肌肉性药物或β3上腺受体激动剂:哪一个应该是第一步?
Maria Lucia Gallo1, Mikołaj Przydacz2, Véronique Phé3
1Department of Urology, Tenon Academic Hospital, AP-HP, Sorbonne University, Paris, France; Department of Minimally Invasive and Robotic Urologic Surgery, Careggi University Hospital, University of Florence, Florence, Italy.
European urology focus
|February 28, 2025
概括
选择治疗过活性膀 (OAB) 的第一种药物包括考虑药物的耐受性以及有效性. 患者特异性因素和共享决策对于最佳治疗选择至关重要.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
背景情况:
- 抗肌肉癌药物一直是过活性膀 (OAB) 的主要治疗方法.
- 贝塔-3上腺受体激动剂为OAB管理提供了新的治疗选择.
- 目前的指导方针缺乏对OAB的明确一线药物建议.
研究的目的:
- 为了比较抗肌肉类药物和β-3上腺素受体激动剂对OAB的有效性和耐受性.
- 为选择过活性膀的初始药物治疗提供指导.
- 在OAB治疗决策中强调以患者为中心的护理的重要性.
主要方法:
- 对OAB药物治疗的现有文献的审查.
- 对临床试验数据的分析,比较抗糖药和β-3激动剂.
- 考虑患者的临床特征和不良事件的危险因素.
主要成果:
- 抗肌肉类药物和β-3上腺受体激动剂在改善OAB症状方面表现出相似的有效性.
- 在这两类药物之间,耐受性概况显著不同.
- 患者的年龄,神经疾病,并发症和不良事件风险因素影响药物选择.
结论:
- 在最初的OAB治疗中,在抗糖药和β-3激动剂之间进行选择时,应优先考虑个体患者的特征和耐受性.
- 当特定的临床指标不有利于一种药物类别而不是另一种药物类别时,将患者的价值观和偏好纳入共同决策至关重要.
- 个性化治疗策略有助于改善过度活动膀综合征的管理.
相关概念视频
Cholinergic Antagonists: Pharmacological Actions
751
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
751
Cholinergic Antagonists: Pharmacokinetics
396
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
396
Antiasthma Drugs: Muscarinic Receptor Antagonists
210
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
210
Cholinergic Antagonists: Therapeutic Uses
699
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
699
Adrenergic Agonists: Direct-Acting Agents
1.3K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.3K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K


